Lipids are a heterogeneous group of small hydrophobic or amphiphilic compounds that are directly involved in membrane trafficking, regulating membrane proteins, cellular structure, and creating specific sub-compartments in membranes that contribute to cellular function. Several studies have shown that abnormal lipid metabolism is highly correlated with various diseases. Lipidomics will therefore become an essential toolkit in cellular and molecular medicine.
BOC Sciences has developed mass spectrometry (MS) and deuterium labeling-based lipid quantification techniques for monitoring quantitative changes in lipids between normal and disease states to understand the pathophysiology and reveal the biology of various diseases associated with lipid metabolism landmark. Our technique not only provides efficient quantitative dynamic range with reasonable accuracy and precision, but is more cost-effective.
Entrust your lipidomics research to scientists at BOC Sciences, who have decades of collective experience in lipid synthesis, purification, and characterization. Our lipid analysis laboratories are equipped with state-of-the-art chromatography/mass spectrometry systems and data analysis software, enabling us to provide quantitative lipidomics services to meet your specific project needs.
Fig.1 General Workflow of Lipidomics.
Timely updates, interactive real-time data review, and strictly confidential comprehensive reporting
The partial deuterium labeling strategy employed by BOC Sciences is more cost-effective for isotopic enrichment in target molecules. Ease of management and low cost make our technique suitable for long-term quantitative analysis of a wider range of biological systems, including plants and mammals. In addition, we were able to D-label various biomolecules such as proteins and carbohydrates, showing that our technique is equally applicable to other quantitative omics studies.
If you are interested in our services, please contact us immediately, then fill in the complete inquiry form, and we will reply to you as soon as possible.
BOC Sciences' DCL™ platform provides a deuterium strategy for both high-end custom markets and basic product needs. Our main business areas cover drug development, omics analysis, scientific research testing, and other markets, and strive to promote the development of biomedicine and scientific research.